GNS.L | Ticker Profile - Titan Protect

GNS.L

Genus plc

Healthcare · Biotechnology · LSE

$2,256.00

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$1.6B

Total market value of the company

Trailing P/E

34.31

Premium valuation

Forward P/E

23.37

Based on estimated future earnings — lower means cheaper

Rev Growth

-0.2%

Year-over-year revenue change

Profit Margin

7.1%

How much profit the company keeps from each dollar of revenue

ROE

9.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$3,200.00

+42% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 12 analysts covering this stock

About Genus plc

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

https://www.genusplc.com

Country: United Kingdom Employees: 3,190 Industry: Biotechnology

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.556

Good returns relative to risk taken

Kelly Fraction

0.0137

Marginal edge — very small allocation suggested

Calmar Ratio

0.469

Drawdown risk outweighs the returns — higher risk profile

Annual Return

15.9%

Historical annualised return based on price data

Max Drawdown

-33.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.90

Less volatile than the market — more defensive

52W High

$3,228.80

30% below the year high

52W Low

$1,890.00

19% above the year low

Avg Volume

198,826

Average daily shares traded — higher means easier to buy and sell

Short Ratio

N/A

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

135.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$0.71

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

51.74

Heavy leverage — higher financial risk if revenues decline

Current Ratio

2.25

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

1.25

Like current ratio but excludes inventory — stricter test

Gross Margin

40.1%

Revenue left after cost of goods — higher means pricing power

Operating Margin

14.5%

Profit from core operations before interest and tax

Free Cash Flow

$30M

Positive — the business generates more cash than it spends

Revenue (TTM)

$672M

Total revenue over the last 12 months

Net Income

$48M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$3,700.00

Target Median

$3,200.00

Target Low

$2,550.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go